Hyperhomocyst(e)inemia as a risk factor after renal transplantation

Area of Science:

• Nephrology
• Cardiology
• Transplantation Medicine

Background:

• Cardiovascular disease (CVD) is a primary cause of mortality in renal transplant recipients.
• Identifying and managing CVD risk factors is critical in this patient population.

Purpose of the Study:

• To review established risk factors for cardiovascular disease in renal transplant recipients.
• To discuss the potential role of additional factors, such as elevated homocysteine levels, in CVD development.

Main Methods:

• Literature review of accepted cardiovascular disease risk factors.
• Discussion of emerging or less-understood risk factors in the context of renal transplantation.

Main Results:

• Established CVD risk factors remain significant in renal transplant recipients.
• Increased homocysteine levels are highlighted as a potential contributing factor to CVD in this group.

Conclusions:

• Managing traditional CVD risk factors is essential for improving outcomes in renal transplant patients.
• Further investigation into non-traditional risk factors like homocysteine may offer new therapeutic targets.